Workshop on RNA therapeutics, Lisbon, Portugal
4 March 2010 - 4 March 2010
Portugal
A workshop on ribonucleic acid (RNA) therapeutics will be held in Lisbon, Portugal on 4 to 5 March 2010.
RNA molecules have been proven to be a key target for disease therapy as well as a tool for the development of new drugs. Since the discovery of small non-coding RNAs, and associated phenomena like RNA interference, the possibility of using RNA-based drugs has become a subject of great interest in the pharmaceutical and clinical fields.
The event will bring together specialists in the clinical area and in the basic experimental research within the field to discuss the forthcoming and present goals of RNA therapeutics. State of the art technologies and applications of RNA molecules as drugs or targets for therapeutics will be presented by prestigious invited speakers. Topics will range from targeted delivery of RNA molecules to applications of RNA technology, microRNAs and their antagonists, use of therapeutic aptamers, and splice-switching strategies.
The workshop is intended for a wide audience of biomedical scientists from academia as well as industry. Students and post-docs enrolled in MD/PhD or translational research programs are particularly welcome.For further information, please visit:
http://www.hmsportugal.org/(opens in new window)
RNA molecules have been proven to be a key target for disease therapy as well as a tool for the development of new drugs. Since the discovery of small non-coding RNAs, and associated phenomena like RNA interference, the possibility of using RNA-based drugs has become a subject of great interest in the pharmaceutical and clinical fields.
The event will bring together specialists in the clinical area and in the basic experimental research within the field to discuss the forthcoming and present goals of RNA therapeutics. State of the art technologies and applications of RNA molecules as drugs or targets for therapeutics will be presented by prestigious invited speakers. Topics will range from targeted delivery of RNA molecules to applications of RNA technology, microRNAs and their antagonists, use of therapeutic aptamers, and splice-switching strategies.
The workshop is intended for a wide audience of biomedical scientists from academia as well as industry. Students and post-docs enrolled in MD/PhD or translational research programs are particularly welcome.For further information, please visit:
http://www.hmsportugal.org/(opens in new window)